Rare diseases
Investigational molecules
Locations
Study of inavolisib, ribociclib, and fulvestrant for patients with advanced hormone-receptor-positive, HER2-negative breast cancer.
ItalyA study of mRNA-4157 and a drug combination for patients with stage IV non-small cell lung cancer
ItalyA study to evaluate the safety and effectiveness of KPL-387 in patients with well-controlled recurrent pericarditis
ItalyA study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection
ItalyA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
ItalyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
ItalyEvaluating the efficacy of pirtobrutinib and epcoritamab in patients with untreated Richter transformation of chronic lymphocytic leukemia
ItalyA study of YL201 and atezolizumab for patients with advanced solid tumors
ItalyStudy to evaluate the efficacy and safety of deucrictibant for the prevention and treatment of angioedema attacks in adults with acquired angioedema
ItalyItalyA study of emavusertib and zanubrutinib in patients with chronic lymphocytic leukemia and other B-cell cancers.
ItalyA study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.
